Burning Rock Reports Third Quarter 2024 Financial Results
December 03, 2024 23:59 ET
|
Burning Rock Biotech Limited
Burning Rock Reports Third Quarter 2024 Financial Results
Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024
December 03, 2024 06:45 ET
|
Burning Rock Biotech Limited
Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
November 05, 2024 09:00 ET
|
PrognomiQ
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
October 10, 2024 23:16 ET
|
Burning Rock Biotech Limited
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
Burning Rock Announces Changes to Management and Board of Directors
September 27, 2024 08:37 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) (the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Reports Second Quarter 2024 Financial Results
August 22, 2024 23:59 ET
|
Burning Rock Biotech Limited
Burning Rock Reports Second Quarter 2024 Financial Results
Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
August 19, 2024 02:21 ET
|
Burning Rock Biotech Limited
Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares
Diadem Appoints Michael Rasche as Chief Executive Officer
July 10, 2024 07:00 ET
|
Diadem SpA
Industry veteran Michael Rasche named CEO of Diadem, a leader in developing blood tests for the early prediction of progression to Alzheimer’s disease.
Global Cancer Diagnostics Market Size To Exceed USD 323.17 Billion By 2033 | CAGR of 8.71%
July 01, 2024 20:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , July 01, 2024 (GLOBE NEWSWIRE) -- The Global Cancer Diagnostics Market Size is to Grow from USD 140.25 Billion in 2023 to USD 323.17 Billion by 2033, at a CAGR of 8.71%...
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
June 03, 2024 00:41 ET
|
Burning Rock Biotech Limited
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement